文献库搜索 | GeneLibs

Henderson(A),Zheng(AM),Daraiseh(S),Khayyat... Avicenna J Med 2026-01-00

...KRAS, EGFR, ALK, BRAF, and MET were identified using targeted NGS panels. Smoking exposure and duration of U.S. residenc...

Eslinger(C),Sonbol(MB),George(B),Babiker(H... Drug Des Devel Ther None

...KRAS as the dominant oncogenic driver in PDAC. Long considered undruggable, KRAS has recently become a viable therapeuti...

Forest(F) Ann Pathol 2026-03-31

...KRAS, STK11, and KEAP1mutation testing. Finally, clones of these antibodies can show different results in terms of sensi...

Niu(S),Molberg(K),Carrick(K),Colon(GR),Gwi... Int J Gynecol Pathol 2026-07-01

...KRAS (36%), ARID1A (27%), ATR (27%), KMT2D (27%), PIK3CA (18%), PIK3R1 (18%), PTEN (18%), AKT1 (18%), TP53 (18%), and se...

Huang(F),Du(Q),Yu(R),Chen(H),Huang(Y),Han(... Spectrochim Acta A Mol Biom... 2026-09-05

...KRAS sequence based on Bsu DNA polymerase inserting adenine opposite 8-oxoG. And then EXPAR could proceed along with the...

Iwasaki(M),Ando(T),Fujii(K),Watanabe(K),Od... Clin Lung Cancer 2026-05-00

...KRAS, KEAP1, and STK11, with genes from exploratory screening. We tested KRAS-KEAP1 and KRAS-STK11 interactions. Sensiti...

Abdelwahab(MM),Soliman(M),Nassrallah(A) BMC Pharmacol Toxicol 2026-04-02

BACKGROUND: KRAS mutations are approximately 25% of human cancers, with particularly high incidence in breast and lung c...

Kramer(M),Belleau(P),Tortora(SC),Deschenes... medRxiv 2026-03-28

...KRAS variants in AFR tumors. Colon cancer genomes in patients in this study also exhibit distinct patterns of DNA copy n...

Yuan(Z),Yu(Z),Xu(Q),Huang(D),Cui(D) Front Immunol None

...KRAS signaling within specific tumor niches adjacent to THBS1-enriched immune regions. High USP54 expression was frequen...

Lin(KH),Lin(YJ),Hong(YB),Hsu(MH),Liao(ZX),... Oncol Res None

...KRAS promoter G4 DNA polymerase stop assay, BG4 immunofluorescence, and KRAS qPCR. PRS was used to optimize GACC-metform...